Carlsmed (CARL) Shares Outstanding (Weighted Average) (2024 - 2026)

Carlsmed (CARL) has 3 years of Shares Outstanding (Weighted Average) data on file, last reported at $26.8 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) rose 524.16% year-over-year to $26.8 million; the trailing twelve-month figure through Mar 2026 stood at $26.8 million (up 524.16% YoY), and the FY2025 full-year result was $14.2 million, up 249.74% from the prior year.
• Shares Outstanding (Weighted Average) for Q1 2026 stood at $26.8 million, up from $14.2 million in the prior quarter.
• Across five years, Shares Outstanding (Weighted Average) topped out at $26.8 million in Q1 2026 and bottomed at $4.0 million in Q2 2024.
• The 3-year median for Shares Outstanding (Weighted Average) is $4.4 million (2025), against an average of $9.0 million.
• The widest annual swing landed in 2025, when Shares Outstanding (Weighted Average) advanced 14.04%; it then soared 524.16% in 2026.
• A 3-year view of Shares Outstanding (Weighted Average) shows it stood at $4.1 million in 2024, then soared by 249.74% to $14.2 million in 2025, then jumped by 88.69% to $26.8 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $26.8 million (Q1 2026), $14.2 million (Q4 2025), and $10.1 million (Q3 2025), per Business Quant data.

Peer Comparison